Retrospective analyses of clinical tumor samples identify TGFβ1 as the most prevalent TGFβ isoform in most solid cancers Preclinical results demonstrate highly selective inhibition of TGFβ1 activation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback